|
Get
Set and raring to go
A number of blockbuster drugs are expected to go off-patent
and the biotech industry is waiting with bated breath, to
witness the rise of the biogenerics. However, there are certain
challenges, which, if not tackled skilfully, may change the
picture completely, Nandini Patwardhan discovers.
Upfront
Upcoming
Events
'Making
vaccines is serious business'
The vaccines market is considered to be a difficult segment
of pharma business. Rajesh Jain, the Joint Managing Director
of Panacea Biotec, discusses some of the issues associated
with vaccine manufacturing with Nandini Patwardhan.
Actavis
expands operations in India
Actavis Group, an international generic pharmaceuticals company
announced that it has signed definitive agreements to acquire
a manufacturing plant for an undisclosed amount. The plant
is to be acquired from Grandix Pharmaceuticals, a manufacturing
and marketing company based in Chennai.
Wockhardt
launches Ondansetron Injection in US
Wockhardt's US subsidiary has launched Ondansetron Injection
in the United States, the first working day after the patent
for the product expired on December 24.
Ranbaxy
gets final ok to market Simvastatin
Ranbaxy Laboratories Limited (RLL), announced that the company
has received approval from the US Food and Drug Administration
to manufacture and market Simvastatin Tablets USP, 5 mg, 10
mg, 20 mg and 40 mg in the US.
Plethico
eyes US firms for acquisitions
Plethico Pharmaceuticals is evaluating two companies in the
United States for acquisition to gain entry into the world's
largest drug market, a company official said.
DRL
gets Para IV for Ondansetron Tablets
Dr Reddy's Laboratories announced that the US Food and Drug
Administration has granted final approval for the company's
ANDA for Ondansetron Hydrochloride Tablets, 4 mg, 8mg, 16
mg and 24 mg.
Roquette
announces continuous commitment to mannitol
Roquette, a world leader in polyols (sugar alcohols) and one
of Europe's largest and most advanced starch producers, has
announced an investment to increase its mannitol production
with a new capacity in its US facilities.
Hot
right now
|
